Low-Dose, Single-Agent Temsirolimus for Relapsed Mantle Cell Lymphoma Ansell, Stephen M. , Inwards, David J. , Rowland, Kendrith M. ... - - Cancer - 2008 Manuscript - Primary - Primary - Lymphoma - N0186
The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9 Barton, Debra L. , Burger, Kelli , Novotny, Paul J. , Fitch, Tom R. ... - - Support Care Cancer - 2013 Manuscript - Primary - Primary - Symptom Inter - N00C9
Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177 Brown, Paul D. , Krishnan, Sunil , Sarkaria, Jann N. , Wu, Wenting ... - - J Clin Oncol - 2008 Manuscript - Primary - Primary - Neuro-Onc - N0177
Phase 2 Trial of Pemetrexed Disodium and Carboplatin in Previously Untreated Extensive-Stage Small Cell Lung Cancer, N0423 Chee, Cheng E. , Jett, James R. , Bernath, Albert M. ... - - Cancer - 2010 Manuscript - Primary - Primary - Respiratory - N0423
Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention. Croghan, Ivana T , Hurt, Richard D , Dakhil, Shaker R ... - - Mayo Clin. Proc. - 2007 Manuscript - Primary - Primary - Prevention - NCCTG-N99C4
A Front-Line “Window of Opportunity” Phase II Study of Sorafenib in Patients with Advanced Non-small Cell Lung Cancer (NSCLC)– A North Central Cancer Treatment Group Study N03261 Dy, Grace K. , Hillman, Shauna L. , Rowland, Kendrith M. ... - - Cancer - 2010 Manuscript - Primary - Primary - Respiratory - N0326
Prognostic factors differ by tumor stage for Small Cell Lung Cancer: A Pooled Analysis of North Central Cancer Treatment Group (NCCTG) Trials Foster, Nathan R. , Mandrekar, Sumithra J. , Schild, Steven E. ... - - Cancer - 2009 Manuscript - Secondary - Primary - Respiratory - N0424
Bortezomib, Paclitaxel, and Carboplatin as a First-Line Regimen for Patients with Metastatic Esophageal, Gastric, and Gastroesophageal Cancer: Phase II Results from the North Central Cancer Treatment Group (N044B)1 Jatoi, Aminah , Dakhil, Shaker R. , Foster, Nathan R. , Ma, Cynthia ... - - J Thorac Oncol - 2008 Manuscript - Primary - Primary - GI - N044B
Prophylactic Tetracycline Does Not Diminish the Severity of Epidermal Growth Factor Receptor (EGFR) Inhibitor Induced Rash: Results from the North Central Cancer Treatment Group (Supplementary N03CB)1 Jatoi, Aminah , Dakhil, Shaker R. , Sloan, Jeff A. , Kugler, John W. ... - - Support Care Cancer - 2011 Manuscript - Secondary - Primary - Symptom Inter - N03CB
Is social support associated with improved clinical outcomes in geriatric lung cancer patients? Observations from North Central Cancer Treatment Group Studies N9921 and N0222 Jatoi, Aminah , Hillman, Shauna L , Ziegler, Katie L Allen ... - - Cancer Manag Res - 2009 Manuscript - Secondary - Comprehensive - Respiratory - N0222 , N9921
Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8 Kearns, Ann E. , Northfelt, Donald W. , Dueck, Amylou C. ... - - Support Care Cancer - 2010 Manuscript - Primary - Primary - Symptom Inter - N01C8
Phase III Noninferiority Trial Comparing Irinotecan With Oxaliplatin, Fluorouracil, and Leucovorin in Patients With Advanced Colorectal Carcinoma Previously Treated With Fluorouracil: N9841 Kim, George P. , Sargent, Daniel J. , Mahoney, Michelle R. ... - - J Clin Oncol - 2009 Manuscript - Primary - Primary - GI - N9841
The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial Kottschade, Lisa A. , Sloan, Jeff A. , Mazurczak, Miroslaw A. ... - - Support Care Cancer - 2011 Manuscript - Primary - Primary - Symptom Inter - N05C3
Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51. Kurtz, David M , Tschetter, Loren K , Allred, Jacob B ... - - Leuk. Lymphoma - 2007 Manuscript - Primary - Primary - Lymphoma - NCCTG-91-78-51
Phase III, Randomized, Double-Blind, Placebo-Controlled Evaluation of Pregabalin for Alleviating Hot Flashes, N07C1 Loprinzi, Charles L. , Qin, Rui , Baclueva, Ernie P. ... - - J Clin Oncol - 2010 Manuscript - Primary - Primary - Symptom Inter - N07C1
A dose-escalation study of aerosolized sargramostim in the treatment of metastatic melanoma: an NCCTG study1 Markovic, Svetomir N. , Suman, Vera J. , Nevala, Wendy K. ... - - Am J Clin Oncol - 2008 Manuscript - Primary - Primary - Experimental - N0071
Exploring Therapeutic Decisions in Elderly Patients with Non-Small Cell Lung Cancer: Results and Conclusions from North Central Cancer Treatment Group Study N0222 McKean, Heidi , Stella, Philip J. , Hillman, Shauna L. ... - - Cancer Invest. - 2011 Manuscript - Secondary - Primary - Respiratory - N0222
Phase II trial of oxaliplatin/irinotecan/5-fluorouracil/leucovorin for metastatic colorectal cancer. McWilliams, Robert R , Goetz, Matthew P , Morlan, Bruce W ... - - Clin Colorectal Cancer - 2007 Manuscript - Primary - Primary - GI - N0341
Phase II Trial of Sorafenib in Patients With Metastatic Breast Cancer Previously Exposed to Anthracyclines or Taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336 Moreno-Aspitia, Alvaro , Morton, Roscoe F. , Hillman, David W. ... - - J Clin Oncol - 2009 Manuscript - Primary - Primary - Breast - N0336
A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma: a North Central Cancer Treatment Study, N0021. Okuno, Scott H , Delaune, Robert , Sloan, Jeff A , Foster, Nathan R ... - - Cancer - 2008 Manuscript - Primary - Primary - Respiratory - N0021
Pretreatment Quality of Life Is an Independent Prognostic Factor for Overall Survival in Patients with Advanced Stage Non-small Cell Lung Cancer Qi, Yingwei , Schild, Steven E. , Mandrekar, Sumithra J. ... - - J Thorac Oncol - 2009 Manuscript - Secondary - Primary - Respiratory - N0424
Brief report: a phase II "window-of-opportunity" frontline study of the MTOR inhibitor, temsirolimus given as a single agent in patients with advanced NSCLC, an NCCTG study. Reungwetwattana, Thanyanan , Molina, Julian R ... - - J Thorac Oncol - 2012 Manuscript - Primary - Primary - Respiratory - N0323
Brain Metastases From Melanoma Schild, Steven E. , Behl, Deepti , Markovic, Svetomir N. ... - - Am. J. Clin. Oncol. - 2010 Manuscript - Primary - Primary - Neuro-Onc - N0274
North Central Cancer Treatment Group (NCCTG) N0537: Phase II Trial of VEGF-Trap in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and/or a Taxane Sideras, Kostandinos , Dueck, Amylou C. , Hobday, Timothy J. ... - - Clin. Breast Cancer - 2012 Manuscript - Primary - Primary - Breast - NCCTG-N0537
Placebo-Controlled Trial to Determine the Effectiveness of a Urea/Lactic Acid–Based Topical Keratolytic Agent for Prevention of Capecitabine-Induced Hand-Foot Syndrome: North Central Cancer Treatment Group Study N05C5 Wolf, Sherry L. , Qin, Rui , Menon, Smitha P. , Rowland, Kendrith M. ... - - J Clin Oncol - 2010 Manuscript - Primary - Primary - Symptom Inter - N05C5
A Phase I/II Study of Bortezomib in Combination with Paclitaxel, Carboplatin and Concurrent Thoracic Radiation Therapy for Non-Small Cell Lung Cancer: NCCTG-N0321 Zhao, Yujie , Foster, Nathan R. , Meyers, Jeffrey P. ... - - J Thorac Oncol - 2015 Manuscript - Primary - Primary - Respiratory - NCCTG-N0321
